By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
As healthcare innovation continues to accelerate, the role of impact investors and venture philanthropists has become increasingly vital. These funders are not only focused on financial returns but also on advancing health equity, improving patient outcomes, and addressing pressing unmet needs across the life science ecosystem.
At RESI Boston this September, the Impact Investors & Venture Philanthropy Panel will spotlight how this unique group of investors deploys capital to drive meaningful change in healthcare. Panelists will share their perspectives on how they define and measure impact, what differentiates their investment approach from traditional venture capital, and how they partner with founders to align their mission with milestone-driven growth. Attendees will gain a deeper understanding of how these organizations catalyze innovation in areas often overlooked by mainstream funding.
This discussion will feature:
 |
 |
 |
| David Fogel Member of Screening & Due Diligence Committees Mass Medical Angels (Moderator) |
Jonathan Behr Partner Dementia Discovery Fund |
Andres Hurtado-Lorenzo SVP, Translational Research & IBD Ventures Crohn’s and Colitis Foundation |
 |
 |
|
| Ron Levin Managing Partner Alumni Ventures |
Stephanie Oestreich Managing Director Myeloma Investment Fund |
The panel will highlight strategies that are shaping a more inclusive and outcomes-focused future for healthcare through impact-driven investing.
Register today to join this discussion and connect with investors, entrepreneurs, and innovators at RESI Boston.
Next Phase Newsletter 
Leave a comment